Clinical Trial Update: A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SM04690 for knee osteoarthritis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• SM04690 (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-18